Headquarters
1812 ASHLAND AVE STE 100, BALTIMORE, MD 21205-1546, US
BALTIMORE, MD, US
ALIQUANTUMRX INC
From the company
AliquantumRx is a near-clinical infectious-disease company focused on eliminating liver-stage malaria relapse. It is developing Cethromycin HCl through its CALM (Cethromycin Against Liver-Stage Malaria) program, a short-course, G6PD testing-independent oral therapy designed to eliminate dormant liver-stage malaria and prevent relapse. The company is supported by over $6M in non-dilutive funding for IND-enabling studies and early clinical development and is pursuing human proof-of-concept and potential Priority Review Voucher eligibility.
Products & services offered
Capabilities 3
Facilities
Send your requirements
Quantities, certifications, and timing.